Proliferative Diabetic Retinopathy (PDR) Completed Phase 2 Trials for Aflibercept (DB08885)

Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic

IndicationStatusPhase
DBCOND0056889 (Proliferative Diabetic Retinopathy (PDR))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02863354
Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic RetinopathyTreatment